Validation experiment designed to validate causal mechanisms targeting TARDBP in TDP-43 mutant mice. Primary outcome: neuroinflammatory cytokine profile
Investigation of cGAS/STING pathway activation in TDP-43 mutant mice to validate the role of this innate immune signaling cascade in ALS" class="entity-link entity-disease" title="disease: ALS">ALS pathology in vivo. The study examined whether pharmacologic inhibition or genetic deletion of cGAS and STING components could prevent the neuroinflammatory phenotype associated with TDP-43 mutations in the mouse model.
Analysis of TDP-43 mutant mice with pharmacologic inhibition or genetic deletion of cGAS/STING components, assessment of inflammatory markers and pathology
cGAS/STING inhibition reduces neuroinflammation in TDP-43 mutant mice
Decreased inflammatory cytokine levels and reduced pathology
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.